The FAES Academic Programs at NIH offers a unique Advanced Studies in Technology Transfer to persons with a Bachelor’s degree in science or engineering or a related field. Courses are offered in the evenings, making it convenient for working professionals and postgraduate Fellows to gain expertise and experience in patenting, licensing, collaborative agreements, and other fundamental intellectual property transactions. The technology transfer profession field employs more than 10,000 professionals in the U.S., with many practicing their trade in the greater Washington, D.C. metro area.The course instructors are leading practitioners in the field, so students can simultaneously gain the necessary knowledge and build professional networks.
Open to persons with a Bachelor's degree or higher in a STEM field. The program comprises a self-paced 15-credit curriculum of required and elective courses that can be completed in approximately two years. The program culminates in an independent Capstone Project through which students will be required to demonstrate their knowledge of the theory and practice of technology transfer by completing a project of their design and choice at the NIH or in their regional community.
CHEM 327 | The Art of Drug Design and Discovery
PHAR 328 | FDA Perspective on Drug Development
TECH 490 | Communication in Biomedical Sciences
TECH 491 | Market Assessment for Innovative Technologies in Biomedical Sciences
TECH495 | The FDA: Science, Health Policy, and Regulation in an Uncertain Environment
TECH 498 | Leadership Strategies in Biomedical Sciences I
TECH 508 | Regulatory Affairs and FDA Regulation
TECH 521 | Tools for Technology Transfer Managers - Handling Intellectual Property, Collaborations, and Agreements
TECH 525 | Legal and Ethical Issues in Public Health and Biomedical Sciences
TECH 528 | Preclinical Evaluation of Novel Drugs and Beyond
TECH 566 | Building a Biotechnology Company: Leadership and Management Strategies
TECH 567 | International Strategic Partnering and Business Development
TECH 572 | Marketing Strategies for Scientific Organizations
TECH 575 | Accounting and IP Valuation for Non-Accountants
TECH 582 | Intellectual Property and Patent Prosecution for Scientists
TECH 583 | Patent Research for Scientists and Engineers
TECH 584 | Translational Medical Product Development
TECH 586 | International Health Science, Technology, and Innovation
TECH 588 | FDA Regulatory Strategy in Medical Product Development
TECH 607 | Capstone Course in Technology Transfer (second time would count as an elective)
Upon completion, students will be able to:
- Understand fundamental technology-transfer processes for transferring scientific findings from one organization to another for the purpose of further development and commercialization
- Explain and describe the role that intellectual property will play in the transition from a manufacturing-based economy to a knowledge-based economy as part of industrial and societal development
- Describe and explain specific technology transfer processes involved with: (1) identifying new technologies; (2) protecting technologies through patents and other forms of intellectual property; and, (3) forming development and commercialization strategies, such as marketing and licensing to existing private sector companies, or creating new startup companies based on the technology
- Learn to apply technology-transfer processes to ensure that new discoveries have the opportunity to reach the stream of commerce and that investments in intellectual property are returned to the public through products that benefit the public and increase employment as well as state and federal taxes
- Understand how commercialization of scientific innovations can be pursued without disrupting the core research institution values of publication and sharing of information, research results, materials, and know-how
Researchers are frequently asked to describe the potential societal implications of their research when applying for fellowships, proposing for research funds, or writing a research paper that is the result of that funding. Yet to write that section, they often need a better understanding of society and public policy, including regulations, which is not always the case.
The workshop will provide an overview of science, technology, and innovation history and policy in the United States with a focus on the National Institutes of Health and how it relates to the expectations that policymakers and the public has of the research community today. Also discussed will be the role that the White House; Congress; federal, state, and local government agencies; foundations; business and industry; and non-governmental organizations play in the implementation of science, technology, and innovation policy.
Students will also learn policy analysis techniques, and then apply those techniques to their own or a colleague’s research activities or one of their own choosing. They will then learn techniques to communicate the results of that analysis to policymakers and the public. This will prepare students interested in careers in research, government, policy-making, or program management.
This course introduces the relevant skills needed for effective oral and written scientific communication in the diverse settings encountered within biomedical vocations. Students will interpret and critically review scientific information, practice oral presentations for defined audiences, and construct effective arguments to inform and/or influence listeners.
Students will have an opportunity to leverage communication models and learning theories within their practice in order to strengthen their speech and authorship qualities. In this course, special emphasis is placed on field-specific activities performed by biomedical professionals, such as communicating with the public or scientifically untrained audiences and ensuring understanding.
After successful completion of this course, students:
- Will understand the elements that are important for communicating effectively to mixed audiences in written and oral formats;
- Will have developed relevant knowledge regarding communication studies theoretical underpinnings pertinent to scientific communication; and
- Will be able to write persuasive, engaging, and effective scientific information.
The course provides an introduction to the financial and business aspects of valuation in biomedical sciences. We use practical presentations and case study methods to give students hands-on valuation experience. Assigning a value to an innovative technology or a valuation to a technology company in biomedical sciences can be seen as challenging, given their novelty. This course helps students identify the assumptions and factors required to establish value. We then develop a framework to help prioritize which factors affect that value the most. Students will learn how to assign current and future worth to a technology, a product, or a company, based on the market potential, market need, and competition. Students will work on projects involving evaluation of a therapeutic, a diagnostic, and/or a life sciences tool/instrument. This course provides the framework for making judgments and valuations, including: Market analysis and market research processes to form assumptions and define elements that contribute to a technology's or a company's value; Market sizing techniques; How to assess a biotech company for financing rounds and M&A; How to consider future value of a product when assessing the value of the intellectual property today; Net present value models in Excel; Assigning value to a management team's expertise and track record; Types of risks (discounting); Excel models for defining market sizes and valuation (NPV). This class is interactive, and students work in groups to allow interactive learning.
Students will learn:
- The basic factors involved in assessing a technology, market or company
- Which concepts, tools and techniques are useful for assessing a market and valuation
- How to assess a company prior to the valuation
- How to value an idea, platform, technology, or company
- How to calculate value of a technology students may currently be working on
- Understanding the key components of a therapeutic product valuation, and which are the key value drivers
- Understanding investors' objectives in considering a biomedical company/product
- Understand the FDA’s mission, how that mission has evolved, and how science informs the FDA’s policy and pro-duct decisions
- Explore potential career paths at the FDA and in industries that produce FDA-regulated products
- Appreciate the importance of effectively communicating FDA’s decisions on a multitude of complex scientific, medical, and public health matters
- Identify the various forces and interests that confront the FDA, and evaluate their potential impact on the agency in an uncertain and evolving political environment
This course focuses on learning to manage and lead people who report to you, across team, and your supervisor. You will learn through scenarios, case studies, and experiential learning, how what you say and do directly impacts outcomes. The roles of managers and leaders in biomedical science companies undergo constant change. This course includes in-depth discussions of leadership skills, communication, conflict resolution, and goal integration. You will have the opportunity to manage and lead your own team to a desired outcome, analyze what works and does not work within the management systems, and suggest alternatives.
- Become familiar with the U.S. legal system and FDA’s administrative regulatory authority
- Learn about FDA’s regulatory oversight over drugs, biologics, medical devices, foods, cosmetics, and tobacco
- Gain an understanding of current FDA news
Technology Transfer Society/Washington, D.C. Chapter This course is an elective for Advanced Studies in Technology Transfer.
This is the first part of a two-part course. Registration is required separately for each part of the course.
- Develop a basic understanding of technology transfer and its role in the biological sciences
- Comprehend the basis and subsequent interaction of technology transfer in the overall developmental process of moving new discoveries to the marketplace
- Gain a greater appreciation of career options in technology transfer
Tools For Technology Transfer Managers — Handling Intellectual Property, Collaborations, and Agreementss
Designed for technology transfer specialists new to the field or scientists and other individuals wanting to learn the nuts and bolts of technology transfer activities, this course will delve into the day-to-day tools utilized by professionals in the field. The course will begin with setting the context with an introduction to intellectual property law and, then, will turn to a focused review of the various types of agreements relating to collaborations, exchanges of materials, license agreements, and clinical trials, along with the potential issues or problems they are designed to address. Finally, the field of technology transfer will be put into a broader context, with a look at its relationship to contracts, grants, and other forms of government/non-government interactions, in addition to customer-service techniques and negotiation tactics. This course is an elective for Advanced Studies in Technology Transfer.
The above course(s) or permission from the instructor.
- Develop a working understanding of basic intellectual property law
- Comprehend the broad regulatory and business framework for technology transfer
- Assess the different tools available for transferring technology, with a focus on federal labs
- Discuss ethical issues, the basis and influence of moral theories on resolving bioethical issues
- Survey the legal, medical, and scientific aspects of current bioethical issues
- Learn about the U.S. patent process and the interdependency of marketplace and laws which regulate it
- Explain how the principles of property and ownership relating to intellectual property and biological materials impact the development of new therapies and diagnostics
- Understand the impact of biotechnology on healthcare and the medical community
- Review the history and fundamentals of pharmacology/toxicology and challenges faced by these disciplines in the drug-approval process
- Discuss how non-clinical study results are interpreted, and how the pharmacology/toxicology discipline assesses hazard identification that affects advice provided regarding safety and efficacy in human clinical trials and for drug approval
- Explain the nonclinical study requirements and types of data reviewed by the pharmacology/toxicology Center for Drug Evaluation and Research (CDER) reviewer discipline
- Discuss how the pharmaceutical industry uses nonclinical studies to make business decisions, including partnering with academic and contract-research organizations, in-licensing, and moving to international markets
- Explore post-marketing safety of drugs via epidemiology, and how nonclinical studies can be used to address after-market safety concerns as well as pharmacy compounding
This course will take a practical, hands-on approach to business plan development, venture capital, and technology transactions. Using current examples from the active technology portfolio of the NIH Office of Technology Transfer or an example of their own choosing, students will learn and participate in reviewing a scientific innovation and determining whether the discovery makes a realistic business proposal. The course will look at the history of venture-capital and its relation to science and technology. The course will emphasize technology-transfer issues (particularly from the NIH standpoint) related to real-world technology partnerships and venture capital investments. Issues related to legal considerations, including due diligence and licensing issues, will be also highlighted. This course is required for Advanced Studies in Technology Transfer.
Basic or advanced knowledge of science; no business credits required.
- Develop an appreciation of the role of venture capital and other investors in the development of new biomedical technologies
- Understand and be able to complete the essential elements of a business plan
- Communicate effectively, orally and in writing, to potential investors the commercial advantages of a new technology
basic or advanced knowledge of science; TECH 565 is helpful, but not required.
- Develop a working understanding of the structure and management of biomedical business firms
- Comprehend the critical thinking needed for management decisions during times of financial hardship and growth
- Be able to effectively interact with biotech stakeholders to discuss issues relating to finance, R&D, marketing, manufacturing, and human resources
This course will assess the growing global marketplace for innovative biomedical products and research, particularly in developing countries, with a focus on business plans, market development, venture capital, technology transactions, and relevant international partnerships. Using current examples from the technology portfolio of NIH and other organizations, students will review scientific innovations and determine whether a particular discovery constitutes a realistic business proposal from an international perspective. This course is an elective for Advanced Studies in Technology Transfer.
Basic or advanced knowledge of science; no business credits required.
- Understand the growing marketplace for innovative biomedical products and research, particularly as they relate to developing countries
- Examine approaches taken by different institutions, including the NIH, and new institutional frameworks such as PDPs
- Assess sources of funding in relation to innovation and the development of biomedical products
- Develop expertise in branding products and companies
- Use market research tools to develop strategies for real technologies
- Interact with guest lecturers to learn how people get to be marketers
- Understand the basics of marketing: Product, Price, Promotion, and Place
Finance and accounting are the language of business, yet this language is not well understood by people in non-profit or scientific research institutions who work with for-profit companies. This course will give an overview of how companies keep score, and how outsiders can understand the financial health of internal activities. The course will make extensive use of financial statements (Annual and Quarterly Reports) from well-known companies and use these reports to introduce principles of financial accounting. These principles will be tied to an understanding of: (1) how an individual can assess the financial stability and capabilities of a partner; (2) how financial issues can impact potential collaborations and deals with companies; (3) how financial issues directly impact agreements in which students may participate. The class will also look at the operation of financial markets, and how the reported financial issues of a company interact with the broader financial markets. Students will make extensive use of publicly available financial information that may be found online. The class will have periodic assignments that will provide an opportunity for students to present their analyses in class.
Experience with or interest in collaborations or agreements with for-profit organizations. This course is an elective for Advanced Studies in Technology Transfer.
- Develop basic understanding of accounting principles and financial statements as they apply to biotech and other life-science companies
- Utilize transactions as the basis for building balance sheets, income statement, and other financial statements
- Analyze the performance of public biotech and life science companies using standard financial tools
- Understand invention, discovery, creative work, secret, and how they can give a business advantage
- Gain a high-level understanding to distinguish between or obtain the four types of IP: patents; trademarks and service marks; copyrights; and, trade secrets in the context of supporting business development
- Describe U.S. patenting process, both historically and in the context of the movement toward global harmonization through international IP frameworks
- Explore some common career options in the IP field, such as patent agents and attorneys, licensing professional, technology transfer professional, technology searcher, and patent examiner
- Draft at least the most important sections of a patent application
A significant amount of scientific information is available in a patent that is not available in any other publication. Therefore, in every stage of research, knowledge of patent data is essential to developing a clear understanding of the state-of-the-art. Designed for scientists, engineers, and researchers, this course teaches students where to find patent data, how they are organized, and what strategies are required to conduct high-quality patent research. An overview of leading patent databases is provided, while students will also receive training and free access to a number of top-tier subscription-based databases for the semester. Databases required for biology and chemistry research are also covered. Students will be exposed to the basic legal framework underlying patent research required at key points of the innovation lifecycle along with strategies for developing state-of-the-art reviews, patentability and invalidity assessments, freedom to operate analysis, and competitive intelligence through patent analytics. This course is an elective for Advanced Studies in Technology Transfer.
- Gain the know-how to develop the search strategy required to make informed research decisions and the ability to select the best resources to conduct patent research in diverse technology areas
- Understand what information is found in patents, and how patent research is leveraged to inform research-related decisions throughout the innovation lifecycle
- Develop an understanding of the basic strategies and legal requirements for common patent research goals required in research
- Acquire knowledge and tools of different aspects of medical product development
- Understand strategic considerations of medical product development
- Discuss the importance of R&D and its impact on science, technology, and health systems internationally
- Understand the NIH model for enhancing public health, R&D, and technology transfer process
- Discuss case studies related to public health and technology transfer applicable to different countries
- Share global health R&D activities and programs at NIH, other U.S. government agencies, international organizations, and institutions in different countries
- Gain an understanding of the history and development of food and drug laws and regulations as applied to drugs, biologics, and medical devices
- Get introduced to processes, regulations, manufacturing practices, reporting, listing, inspection involved in medical device and product development
permission of the instructor. This course is required for Advanced Studies in Technology Transfer. This
course may be taken two times.
- Identify an area related to technology transfer or technology development that is of strong interest to the student and merits further exploration and independent study
- Complete the project for a client or mentor that will focus on a practical experience outcome
- Utilize the project and practical experience obtained as part of a career-development or transition strategy for future employment